Free Trial
Ricky Goldwasser

Ricky Goldwasser Analyst Performance

Analyst at Morgan Stanley

Ricky Goldwasser is a stock analyst at Morgan Stanley, covering 25 publicly traded companies across a range of sectors. Over the past year, Ricky Goldwasser has issued 10 stock ratings, including buy and hold recommendations. While full access to Ricky Goldwasser's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ricky Goldwasser's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
112 Last 11 Years
Buy Recommendations
58.18% 64 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy58.2%64 ratings
Hold32.7%36 ratings
Sell9.1%10 ratings

Out of 110 total stock ratings issued by Ricky Goldwasser at Morgan Stanley, the majority (58.2%) have been Buy recommendations, followed by 32.7% Hold and 9.1% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
64.0% of companies on NYSE
16 companies
NASDAQ
36.0% of companies on NASDAQ
9 companies

Ricky Goldwasser, an analyst at Morgan Stanley, currently covers 25 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
21 companies
84.0%
Retail/Wholesale
2 companies
8.0%
Miscellaneous
2 companies
8.0%

Ricky Goldwasser of Morgan Stanley specializes in stock coverage within the Medical sector, with additional focus on Retail/Wholesale and companies.

Coverage Industries

IndustryPercentage
MED - HMO
4 companies
16.0%
MEDICAL SERVICES
4 companies
16.0%
MED/DENTAL - SUPP
2 companies
8.0%
MED - OUTP/HM CRE
2 companies
8.0%
DRUG STORES & PROPRIETARY STORES
2 companies
8.0%
CUSTOM COMPUTER PROGRAMMING SERVICES
1 company
4.0%
HOSPITAL & MEDICAL SERVICE PLANS
1 company
4.0%
COMPUTER INTEGRATED SYSTEMS DESIGN
1 company
4.0%
COMMERCIAL PHYSICAL RESEARCH
1 company
4.0%
OFFICES & CLINICS OF MEDICAL DOCTORS
1 company
4.0%
HEALTH INFORMATION SERVICES
1 company
4.0%
RETAIL - DRUG STR
1 company
4.0%
PHARMACEUTICAL PREPARATIONS
1 company
4.0%
MED INSTRUMENTS
1 company
4.0%
HOLDING & OTHER INVESTMENT OFFICES
1 company
4.0%
Miscellaneous
1 company
4.0%

Ricky Goldwasser's Ratings History at Morgan Stanley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
8/20/2025Lower Price Target$299.20$325.00Overweight
Centene Corporation stock logo
CNC
Centene
8/4/2025Lower Price Target$26.76$28.00Equal Weight
Labcorp Holdings Inc. stock logo
LH
Labcorp
7/25/2025Boost Price Target$267.42$306.00Overweight
Centene Corporation stock logo
CNC
Centene
7/10/2025Downgrade$33.00$33.00Equal Weight
Labcorp Holdings Inc. stock logo
LH
Labcorp
6/11/2025Boost Price Target$260.48$283.00Overweight
Centene Corporation stock logo
CNC
Centene
6/9/2025Initiated Coverage$55.56$70.00Overweight
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
5/14/2025Lower Price Target$319.37$374.00Overweight
Doximity, Inc. stock logo
DOCS
Doximity
4/24/2025Lower Price Target$55.94$60.00Equal Weight
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4/22/2025Lower Price Target$423.75$563.00Overweight
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
2/5/2025Lower Price Target$162.95$184.00Equal Weight